Biotech

All Articles

Sanofi's $80M bet on Pivot dystrophy medicine ends in phase 3 go bust

.Simply 4 months after Sanofi bet $80 thousand in upfront money on Fulcrum Therapeutics' losmapimod,...

Oncternal stock sinks 60% among discharges, test terminations

.Cancer provider Oncternal Rehabs is actually folding all its clinical trials as well as giving up t...

Roche is actually supporting out hopes that its injectable excessive weight possibility can at some point demonstrate 25% weight-loss in late-stage trial

.Roche is actually holding out chances that its own injectable weight problems possibility might eve...

Novo Nordisk hails 'impressive' weight-loss lead for dual-acting oral medication in very early trial

.Novo Nordisk has actually raised the lid on a stage 1 trial of its dental amylin and also GLP-1 rec...

AbbVie takes legal action against BeiGene over blood cancer cells medication classified information

.Just a handful of quick weeks after succeeding an FDA Fast lane tag for its own investigational BTK...

Lilly delivers one-two punch along with second tranche of beneficial data on weekly insulin prospect

.Quickly after a favorable information decrease for Eli Lilly's efsitora alfa, the Indianapolis-base...

BridgeBio reduces gene treatment budget as scientific information dissatisfy

.BridgeBio Pharma is lowering its own genetics therapy finances as well as drawing back coming from ...

GSK surrenders HSV vaccine hopes after period 2 stop working, transferring nationality to Moderna, BioNTech

.GSK's try to cultivate the first vaccination for genital herpes simplex virus (HSV) has ended in fa...

GSK's long-acting bronchial asthma medicine halved assaults in phase 3

.GSK's long-acting bronchial asthma procedure has actually been actually shown to cut in half the lo...

AstraZeneca, Daiichi unbox Dato-DXd's total survival fall short

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has neglected to impr...